Proteome Sciences (LON:PRM) Shares Down 27.2% – Time to Sell?

Proteome Sciences plc (LON:PRM) dropped 27.2% during mid-day trading on Monday . The stock traded as low as GBX 1.66 and last traded at GBX 2.30. Approximately 328,570 shares were traded during mid-day trading, an increase of 0% from the average daily volume of 327,618 shares. The stock had previously closed at GBX 3.16.

Proteome Sciences Trading Down 36.7%

The company has a market cap of £5.90 million, a P/E ratio of -1.77 and a beta of 0.07. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66. The firm’s 50 day moving average is GBX 2.44 and its two-hundred day moving average is GBX 2.55.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.